Literature DB >> 1227301

Clinical use of naltrexone (EN 1639 A). Part II: experience with the first 50 patients in a New York City treatment clinic.

A Schecter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1227301     DOI： 10.3109/00952997509005667

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN： 0095-2990            Impact factor:   3.829


× No keyword cloud information.
  2 in total

1.  A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.

Authors:  Katharine Cioe; Breanne E Biondi; Rebecca Easly; Amanda Simard; Xiao Zheng; Sandra A Springer
Journal:  J Subst Abuse Treat       Date:  2020-09-22

2.  Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual.

Authors:  Kenneth Blum; Lisa Lott; David Baron; David E Smith; Rajendra D Badgaiyan; Mark S Gold
Journal:  J Syst Integr Neurosci       Date:  2020-05-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.